DIN 02244372 — PACLITAXEL FOR INJECTION 6 MG
PACLITAXEL FOR INJECTION is a solution of Paclitaxel marketed by BIOLYSE PHARMA CORPORATION. The full Paclitaxel monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02244372
- Brand name
- PACLITAXEL FOR INJECTION
- Active ingredient
- Paclitaxel
- Strength
- 6 MG
- Dosage form
- SOLUTION
- Route
- INTRAVENOUS
- Manufacturer
- BIOLYSE PHARMA CORPORATION
- Health Canada status
- MARKETED
- Drug class
- Antineoplastic agent (taxane, antimicrotubule agent)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Paclitaxel products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02281066 | ABRAXANE FOR INJECTABLE SUSPENSION | 100 MG | POWDER FOR SUSPENSION | BRISTOL-MYERS SQUIBB CANADA | MARKETED |
| 02248844 | APO-PACLITAXEL INJECTABLE | 6 MG | SOLUTION | APOTEX INC | DORMANT |
| 02320010 | PACLITAXEL FOR INJECTION USP | 6 MG | SOLUTION | STERIMAX INC | DORMANT |
| 02320150 | PACLITAXEL INJECTION USP | 6 MG | SOLUTION | SANDOZ CANADA INCORPORATED | MARKETED |
| 02391465 | PACLITAXEL INJECTION USP | 6 MG | SOLUTION | ACCORD HEALTHCARE INC | MARKETED |
| 02496097 | PACLITAXEL POWDER FOR INJECTABLE SUSPENSION NANOPARTICLE, ALBUMIN-BOUND PACLITAXEL | 100 MG | POWDER FOR SUSPENSION | PANACEA BIOTEC PHARMA LIMITED | MARKETED |